Cargando…
Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis
INTRODUCTION: Sepsis activates the coagulation system and frequently causes hypercoagulability, which is not detected by routine coagulation tests. A reliable method to evaluate hypercoagulability is thromboelastography (TEG), but this has not so far been used to investigate sepsis-induced hypercoag...
Autores principales: | Gonano, Christopher, Sitzwohl, Christian, Meitner, Eva, Weinstabl, Christian, Kettner, Stephan C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794466/ https://www.ncbi.nlm.nih.gov/pubmed/17107615 http://dx.doi.org/10.1186/cc5098 |
Ejemplares similares
-
Endobronchial intubation detected by insertion depth of endotracheal tube, bilateral auscultation, or observation of chest movements: randomised trial
por: Sitzwohl, Christian, et al.
Publicado: (2010) -
Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
por: Hoffmann, Johannes N, et al.
Publicado: (2007) -
Antithrombin in sepsis revisited
por: Levi, Marcel
Publicado: (2005) -
All that seems sepsis is not sepsis
por: Guleria, Vivek S., et al.
Publicado: (2013) -
Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005)